TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 132 filers reported holding TG THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 1.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $42,816,000 | -33.8% | 1,600,000 | -51.8% | 3.85% | -25.5% |
| Q2 2020 | $64,689,000 | +84.9% | 3,320,808 | -6.6% | 5.17% | +41.4% |
| Q1 2020 | $34,994,000 | -42.0% | 3,556,324 | -34.6% | 3.66% | -30.4% |
| Q4 2019 | $60,326,000 | +390.5% | 5,434,783 | +81.2% | 5.25% | +237.8% |
| Q4 2018 | $12,300,000 | +12.6% | 3,000,000 | +53.8% | 1.56% | -8.6% |
| Q3 2018 | $10,920,000 | – | 1,950,000 | – | 1.70% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 2,813,779 | $33,568,000 | 3.32% |
| Opaleye Management Inc. | 300,000 | $3,579,000 | 1.50% |
| BRIDGER MANAGEMENT, LLC | 3,068,315 | $36,605,000 | 1.21% |
| SECTORAL ASSET MANAGEMENT INC | 1,521,667 | $18,153,000 | 0.77% |
| STONERIDGE INVESTMENT PARTNERS LLC | 332,576 | $3,968,000 | 0.53% |
| Eventide Asset Management | 537,600 | $6,414,000 | 0.32% |
| Baker Brothers Advisors | 2,003,991 | $23,908,000 | 0.20% |
| Quantitative Systematic Strategies LLC | 25,270 | $302,000 | 0.08% |
| Candriam S.C.A. | 236,200 | $2,818,000 | 0.08% |
| COLUMBUS CIRCLE INVESTORS | 705,389 | $8,415,000 | 0.07% |